Clinical Trial Update: Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating epoetin alfa for treating anemia caused by chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Lymphocytic Leukemia

Drugs mentioned

• Epogen (epoetin alfa)
• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Leukemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED